BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2561737)

  • 1. WEHI-3B D+ Y1 leukemia cells as a model system to assess the induction of differentiation in vivo.
    Gamba-Vitalo C; Carman MD; Sartorelli AC
    Cancer Commun; 1989; 1(3):157-65. PubMed ID: 2561737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of the differentiation of WEHI-3B D+ monomyelocytic leukemia cells by inhibitors of topoisomerase II.
    Rappa G; Lorico A; Sartorelli AC
    Cancer Res; 1990 Oct; 50(20):6723-30. PubMed ID: 2170008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of WEHI-3B D+ monomyelocytic leukemia cells by retinoic acid and aclacinomycin A.
    Gamba-Vitalo C; Blair OC; Keyes SR; Sartorelli AC
    Cancer Res; 1986 Mar; 46(3):1189-94. PubMed ID: 3455881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow-cytometric analysis of in vivo induction of differentiation of WEHI-3B myelomonocytic leukemia cells by recombinant granulocyte colony-stimulating factor.
    Hayashi M; Okabe-Kado J; Hozumi M
    Exp Hematol; 1994 Apr; 22(4):393-8. PubMed ID: 7512048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of DNA ploidy in the differentiation of WEHI-3B D- leukemia cells transfected with the granulocyte colony-stimulating factor receptor gene.
    Li J; Koay DC; Sartorelli AC
    Exp Cell Res; 1995 Aug; 219(2):579-88. PubMed ID: 7543855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination with leukemia cells expressing cell-surface-associated GM-CSF blocks leukemia induction in immunocompetent mice.
    Ling X; Wang Y; Dietrich MF; Andreeff M; Arlinghaus RB
    Oncogene; 2006 Jul; 25(32):4483-90. PubMed ID: 16547503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a lacZ marked WEHI-3B D+ murine leukemic cell line as an in-vivo model of acute non-lymphocytic leukemia.
    Smith C; Muench MO; Knizewski M; Gilboa E; Moore MA
    Leukemia; 1993 Feb; 7(2):310-7. PubMed ID: 8426483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cell differentiation action of 4'-epi-adriamycin in WEHI-3B myelomonocytic leukemia cells].
    Kajigaya Y; Ikuta K; Sasaki H; Matsuyama S
    Gan To Kagaku Ryoho; 1991 Nov; 18(14):2409-15. PubMed ID: 1952960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a repressor of the differentiation of WEHI-3B D- leukemia cells.
    Li J; Finch RA; Xiao W; Sartorelli AC
    Exp Cell Res; 1998 Jul; 242(1):274-84. PubMed ID: 9665825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of anti-leukemia molecular mechanism of ITR-284, a carboxamide analog, in leukemia cells and its effects in WEHI-3 leukemia mice.
    Wen YF; Yang JS; Kuo SC; Hwang CS; Chung JG; Wu HC; Huang WW; Jhan JH; Lin CM; Chen HJ
    Biochem Pharmacol; 2010 Feb; 79(3):389-98. PubMed ID: 19765549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of neomycin-resistant WEHI-3B D+ murine cells as an in vivo model of acute nonlymphocytic leukemia.
    Gamba-Vitalo C; Carman MD; Sartorelli AC
    Exp Hematol; 1989 Feb; 17(2):130-7. PubMed ID: 2912737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conjugated linoleic acid induces monocytic differentiation of murine myeloid leukemia cells.
    Lui OL; Mak NK; Leung KN
    Int J Oncol; 2005 Dec; 27(6):1737-43. PubMed ID: 16273230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth and differentiation of a murine interleukin-3-producing myelomonocytic leukemia cell line in a protein-free chemically defined medium.
    Kajigaya Y; Ikuta K; Sasaki H; Matsuyama S
    Leukemia; 1990 Oct; 4(10):712-6. PubMed ID: 1699090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,25-Dihydroxycholecalciferol-induced differentiation of myelomonocytic leukemic cells unresponsive to colony stimulating factors and phorbol esters.
    Bettens F; Schlick E; Farrar W; Ruscetti F
    J Cell Physiol; 1986 Dec; 129(3):295-302. PubMed ID: 3491083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (-)-Menthol inhibits WEHI-3 leukemia cells in vitro and in vivo.
    Lu HF; Liu JY; Hsueh SC; Yang YY; Yang JS; Tan TW; Kok LF; Lu CC; Lan SH; Wu SY; Liao SS; Ip SW; Chung JG
    In Vivo; 2007; 21(2):285-9. PubMed ID: 17436578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of murine leukemia virus infection on long-term hematopoiesis in vitro emphasized by increased survival of bone marrow cultures derived from BALB/Mo mice.
    Greenberger JS; Shadduck RK; Jaenisch R; Waheed A; Sakakeeny MA
    Cancer Res; 1981 Sep; 41(9 Pt 1):3556-65. PubMed ID: 6266658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in tyrosine phosphorylation during the granulocytic maturation of HL-60 leukemia cells.
    Frank DA; Sartorelli AC
    Cancer Res; 1988 Jan; 48(1):52-8. PubMed ID: 2825968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effects of a novel aminosteroid on WEHI-3B leukemia cells].
    He Q; Na XD; Jiang DZ
    Hunan Yi Ke Da Xue Xue Bao; 2000 Oct; 25(5):435-9. PubMed ID: 12212110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The production of differentiation autoinducing activity by WEHI-3B D+ leukemia cells.
    Kajigaya Y; Ikuta K; Sasaki H; Funabiki T; Koiso Y; Matsuyama S
    Exp Hematol; 1989 May; 17(4):368-73. PubMed ID: 2785052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Berberine inhibits WEHI-3 leukemia cells in vivo.
    Yu FS; Yang JS; Lin HJ; Yu CS; Tan TW; Lin YT; Lin CC; Lu HF; Chung JG
    In Vivo; 2007; 21(2):407-12. PubMed ID: 17436595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.